Paper39199152
Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches.
Radosavljevic T and 6 others. Antioxidants (Basel), 2024. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches. Papers, record 39199152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 451-03-47/2023-01/200111 | Faculty of Medical Sciences, University of Kragujevac (JP 27/20) | PubMed | ||
| 451-03-66/2024-03/200110; 451-03-65/2024-03/ 200161; 451-03-66/2024-03/ 200161. | the Ministry of Science, Technical Development, and Innovation of the Republic of Serbia | PubMed |
Source PubMed
References146
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24524207 | Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. | Nutr J | 2014 | https://conductscience.org/library/papers/24524207 | PubMed |
| 2 | 20075336 | Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart. | Circ Res | 2010 | https://conductscience.org/library/papers/20075336 | PubMed |
| 3 | 31776781 | Thiazolidinediones: the Forgotten Diabetes Medications. | Curr Diab Rep | 2019 | https://conductscience.org/library/papers/31776781 | PubMed |
| 4 | 35582982 | The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials. | Obes Rev | 2022 | https://conductscience.org/library/papers/35582982 | PubMed |
| 5 | 31781334 | Recent Insights into the Mitochondrial Role in Autophagy and Its Regulation by Oxidative Stress. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31781334 | PubMed |
| 6 | 38337575 | From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New. | J Clin Med | 2024 | https://conductscience.org/library/papers/38337575 | PubMed |
| 7 | 37284220 | Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37284220 | PubMed |
| 8 | 30689995 | Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/30689995 | PubMed |
| 9 | 38286821 | Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. | Nat Metab | 2024 | https://conductscience.org/library/papers/38286821 | PubMed |
| 10 | 34560555 | Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34560555 | PubMed |
| 11 | 37179826 | Mitochondria: It is all about energy. | Front Physiol | 2023 | https://conductscience.org/library/papers/37179826 | PubMed |
| 12 | 19084501 | TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19084501 | PubMed |
| 13 | 38378752 | Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/38378752 | PubMed |
| 14 | 35052595 | Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/35052595 | PubMed |
| 15 | 36601051 | Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat-High fructose diet. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36601051 | PubMed |
| 16 | 29634314 | Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. | Am J Physiol Endocrinol Metab | 2018 | https://conductscience.org/library/papers/29634314 | PubMed |
| 17 | 33332766 | Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. | Immun Inflamm Dis | 2021 | https://conductscience.org/library/papers/33332766 | PubMed |
| 18 | 31051106 | Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. | Cell | 2019 | https://conductscience.org/library/papers/31051106 | PubMed |
| 19 | 35126806 | Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35126806 | PubMed |
| 20 | 35310936 | Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver. | iScience | 2022 | https://conductscience.org/library/papers/35310936 | PubMed |
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939612 | Glycine Insufficiency as a Metabolic Vulnerability in MASLD: Implications for Precision Nutrition. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939612 | PubMed |
| 42871997 | Hepatic Overexpression of a Novel Soluble Endogenous Transforming Growth Factor β Type II Receptor-Immunoglobulin G1 Fc Fusion Protein (TβRII-SE/Fc) Attenuates Early Stage Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42871997 | PubMed |
| 42825017 | Ferroptosis in metabolic dysfunction-associated steatotic liver disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42825017 | PubMed |
| 42792248 | Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792248 | PubMed |
| 42783783 | Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy. | Metabolites | 2026 | https://conductscience.org/library/papers/42783783 | PubMed |
| 42778566 | Metabolic dysfunction-associated steatotic liver disease-a review of the cardiometabolic perspectives and treatments in children. | Int J Obes (Lond) | 2026 | https://conductscience.org/library/papers/42778566 | PubMed |
| 42764349 | Six-compound cocktail for maturation of human pluripotent stem cell-derived liver spheroids for toxicity prediction. | Nat Commun | 2026 | https://conductscience.org/library/papers/42764349 | PubMed |
| 42737629 | Mitochondrial Distress Signals at the Heart-Liver Interface: Molecular Links Between MASLD and Heart Failure. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737629 | PubMed |
| 42703413 | A Shared EGR1-IL-32-Macrophage Polarisation Signature in Rheumatoid Arthritis and Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42703413 | PubMed |
| 42660368 | Mitochondrial antioxidant therapy fails to improve obese asthma outcomes. | Respir Med | 2026 | https://conductscience.org/library/papers/42660368 | PubMed |
| 42654005 | Polyphenol-Rich Euterpe oleracea Mart. Seed Extract Improves High-Fat-Diet-Induced MASLD Through Modulation of Hepatic Mitochondrial Respiration, Biogenesis, and Redox Homeostasis. | Molecules | 2026 | https://conductscience.org/library/papers/42654005 | PubMed |
| 42646265 | Metabolic Rewiring in MASLD: From Disease Mechanisms to Precision Medicine. | Metabolites | 2026 | https://conductscience.org/library/papers/42646265 | PubMed |
| 42522599 | Autophagy in MASLD: A Metabolic and Precision Medicine Perspective. | Liver Int | 2026 | https://conductscience.org/library/papers/42522599 | PubMed |
| 42510525 | Mitochondrial UQCRC2 as a Redox-Regulatory Node in Metabolic and Cardiometabolic Diseases. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42510525 | PubMed |
| 42506440 | Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD/MASH: Metabolic Mechanisms and Therapeutic Perspectives. | Metabolites | 2026 | https://conductscience.org/library/papers/42506440 | PubMed |
| 42439696 | Mechanisms by Which Plant Extracts Ameliorate Bovine Mastitis Through the Regulation of Mitochondrial Function: A Review. | Cells | 2026 | https://conductscience.org/library/papers/42439696 | PubMed |
| 42412329 | Mitophagy in Metabolic Dysfunction-Associated Fatty Liver Disease: Mechanisms, Regulatory Networks, and Therapeutic Perspectives. | Inflammation | 2026 | https://conductscience.org/library/papers/42412329 | PubMed |
| 42392672 | Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications. | BMJ Open Gastroenterol | 2026 | https://conductscience.org/library/papers/42392672 | PubMed |
| 42326688 | ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (-)-Epicatechin in MASLD. | ACS Omega | 2026 | https://conductscience.org/library/papers/42326688 | PubMed |
| 42305303 | Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42305303 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39199152
GET https://conductscience.org/api/papers/v1/39199152/references?page=2